Viagra in India: Competing against Multiple Cost-Based Competitors and Counterfeits
Price: 200
Add to Cart
Details
Case Code:
CLMM035
Case Length:
2
Period:
Pub Date:
2008
Teaching Note:
NO
Price (Rs):
200
Organization:
Pfizer Inc.
Industry:
Pharmaceuticals & Biotech
Country:
India
Themes:
Brand Strategy ,Advertising & Promotion, Product Launch, Growth Strategy
Abstract
Two years after Pfizer launched its blockbuster drug Viagra in India at a premium price, the world’s largest pharmaceutical company was under pressure to grow the brand in India in the face of multiple cost-based competitors and counterfeits.
Learning Objectives
The case is structured to achieve the following Learning Objectives:
- Pricing decisions
- Consumer Behavior
- and Niche marketing.
Keywords
Multiple cost-based competitors, marketing, pharmaceutical, premium price, Viagra, India, Pfizer, counterfeit, ED market, Manforce, Penegra, Caverta, Ranbaxy, Mankind, Zydus
🌐 International Buyers — Pay via PayPal
Amount: $6 USD
Related Case Studies
| Case Title | Details | Price | Add to Cart |
|---|---|---|---|
|
Case Title The Nirma StoryCase Code: MKTG008 |
Details | 300 | Add to Cart |
|
Case Title IKEA’s ‘Punch’ Moment: Using Reactive Marketing to Build Brand ConnectionCase Code: MKTG493 |
Details | 300 | Add to Cart |
|
Case Title FreeWater: Business Model Innovation Built on a Negatively Priced ProductCase Code: BSTR715 |
Details | 300 | Add to Cart |
|
Case Title Ulta Beauty under CEO Kecia Steelman: Unleashing Growth in a Slowdown?Case Code: BSTR713 |
Details | 500 | Add to Cart |
|
Case Title Advanced Thermovoltaic Systems: Transforming Industrial Waste Heat into Clean PowerCase Code: MKTG490 |
Details | 300 | Add to Cart |